La bourse ferme dans 3 h 22 min
  • CAC 40

    6 229,04
    -50,31 (-0,80 %)
     
  • Euro Stoxx 50

    3 947,43
    +1,37 (+0,03 %)
     
  • Dow Jones

    33 587,66
    -681,50 (-1,99 %)
     
  • EUR/USD

    1,2083
    +0,0007 (+0,06 %)
     
  • Gold future

    1 814,40
    -8,40 (-0,46 %)
     
  • BTC-EUR

    41 098,29
    -5 826,23 (-12,42 %)
     
  • CMC Crypto 200

    1 337,49
    -226,34 (-14,47 %)
     
  • Pétrole WTI

    64,66
    -1,42 (-2,15 %)
     
  • DAX

    15 010,34
    -139,88 (-0,92 %)
     
  • FTSE 100

    6 888,85
    -115,78 (-1,65 %)
     
  • Nasdaq

    13 031,68
    -357,75 (-2,67 %)
     
  • S&P 500

    4 063,04
    -89,06 (-2,14 %)
     
  • Nikkei 225

    27 448,01
    -699,50 (-2,49 %)
     
  • HANG SENG

    27 718,67
    -512,37 (-1,81 %)
     
  • GBP/USD

    1,4033
    -0,0024 (-0,17 %)
     

Transcatheter Mitral Valve Implantation (TMVI) (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 market impact)

ReportLinker
·4 min de lecture

Summary Transcatheter Mitral Valve Implantation (TMVI) (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

New York, July 31, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Transcatheter Mitral Valve Implantation (TMVI) (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 market impact)" - https://www.reportlinker.com/p05948913/?utm_source=GNW


The model discusses in detail the impact of COVID-19 on Transcatheter Mitral Valve Implantation market for the year 2020 and beyond.Valvular heart disease is caused by a defect in one of the four heart valves.

It is common in industrialized countries and has affected millions of people worldwide.

Mitral regurgitation, also known as mitral insufficiency, is caused by insufficient systolic coaptation of the mitral valve leaflets along with a change in the pressure gradient between the atrium and left ventricle. If transcatheter mitral valve implantation devices receive approval for mitral regurgitation, it can also be further evaluated for mitral valve stenosis for many patients hospitalized with severe mitral regurgitation are not eligible for open heart surgery.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes.To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available).

Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Transcatheter Mitral Valve Implantation (TMVI) and evolving competitive landscape -
- Insightful review of the key industry trends.
- Annualized total Intra-Peripheral Transcatheter Mitral Valve Implantation (TMVI) revenue by segment and market outlooks from 2015-2030.
- Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition analysts provide unique country specific insights on the market.
- SWOT analysis for Intra- Transcatheter Mitral Valve Implantation (TMVI)market.
- Competitive dynamics insights and trends provided for Transcatheter Mitral Valve Implantation (TMVI).

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market.Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders.

In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered:

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope
This Market Model gives important, expert insight you won’t find in any other source.

The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
- CMO executives who must have deep understanding of the Transcatheter Mitral Valve Implantation (TMVI) marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy
The model will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving Transcatheter Mitral Valve Implantation (TMVI) market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Transcatheter Mitral Valve Implantation (TMVI) market in the future.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Transcatheter Mitral Valve Implantation (TMVI) market from 2015-2030.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Read the full report: https://www.reportlinker.com/p05948913/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001